Cordycepin diminishes thymic stromal lymphopoietin-induced interleukin-13 production

被引:11
作者
Yoou, Myoung-schook [1 ]
Yoon, Kyoung Wan [2 ]
Choi, Youngjin [3 ]
Kim, Hyung-Min [1 ]
Jeong, Hyun-Ja [3 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Dept Pharmacol, 26 Kyungheedae Ro, Seoul 02447, South Korea
[2] Hoseo Univ, Dept Biotechnol, 20,Hoseo Ro 79beon Gil, Asan 31499, Chungcheongnam, South Korea
[3] Hoseo Univ, Dept Food Sci & Technol, 20,Hoseo Ro 79beon Gil, Asan 31499, Chungcheongnam, South Korea
关键词
Cordycepin; Thymic stromal lymphopoietin; Interleukin-13; Signal transducer and activator of transcription; 6; Murine double minute 2; MAST-CELL ACTIVATION; ATOPIC-DERMATITIS; SIGNALING PATHWAYS; TSLP; MDM2; APOPTOSIS; PROLIFERATION; INFLAMMATION; EXPRESSION; OPPORTUNITIES;
D O I
10.1016/j.ejphar.2017.02.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Atopic dermatitis (AD) is known to aggravate by thymic stromal lymphopoietin (TSLP) and TSLP is also known to up-regulate mast cell proliferation via production of interleukin (IL)-13. Thus, we investigated whether cordycepin could regulate mast cell proliferation induced by TSLP in human mast cell line, HMC-1 cell. Cordycepin significantly diminished the production and mRNA of IL-13 through the down-regulation of phosphorylated-signal transducer and activation of transcription 6 in the TSLP-stimulated HMC-1 cells. Cordycepin also significantly diminished the cell proliferation via down-regulating MDM2 and Bc12 levels and up-regulating p53, caspase-3, and cleaved poly ADP-ribose polymerase levels in the TSLP-stimulated HMC-1 cells. Moreover, cordycepin significantly diminished the production of IL-6, tumor necrosis factor-alpha, and IL-1 beta in the TSLP-stimulated HMC-1 cells. In conclusion, our study shows that cordycepin has potential effect for the treatment of allergic inflammatory diseases through the blockade of IL-13 and MDM2 exacerbated by TSLP.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 35 条
[1]  
Bang BR, 2013, SIA PAC ALLERGY, V3, P194
[2]  
Correale CE, 1999, AM FAM PHYSICIAN, V60, P1191
[3]   Proinflammatory cytokines [J].
Dinarello, CA .
CHEST, 2000, 118 (02) :503-508
[4]   Integrated signalling pathways for mast-cell activation [J].
Gilfillan, AM ;
Tkaczyk, C .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) :218-230
[5]   TSLP Induces Mast Cell Development and Aggravates Allergic Reactions through the Activation of MDM2 and STAT6 [J].
Han, Na-Ra ;
Oh, Hyun-A ;
Nam, Sun-Young ;
Moon, Phil-Dong ;
Kim, Do-Won ;
Kim, Hyung-Min ;
Jeong, Hyun-Ja .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (10) :2521-2530
[6]   Signaling mechanisms, interaction partners, and target genes of STAT6 [J].
Hebenstreit, Daniel ;
Wirnsberger, Gerald ;
Horejs-Hoeck, Jutta ;
Duschl, Albert .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (03) :173-188
[7]   Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 [J].
Honda, R ;
Tanaka, H ;
Yasuda, H .
FEBS LETTERS, 1997, 420 (01) :25-27
[8]  
Iwakuma T, 2003, MOL CANCER RES, V1, P993
[9]   The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis [J].
Jariwala, S. P. ;
Abrams, E. ;
Benson, A. ;
Fodeman, J. ;
Zheng, T. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (11) :1515-1520
[10]   Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis [J].
Jones, SN ;
Hancock, AR ;
Vogel, H ;
Donehower, LA ;
Bradley, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15608-15612